Immunoregulatory roles for fc receptor-like molecules

Current Topics in Microbiology and Immunology

Volumn 350, Issue , 2010, Pages 89-104

  Ehrhardt, Gotz R A ^a   Cooper, Max D ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Georgia Research Alliance   (United States)

^c EMORY CENTER FOR AIDS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; FC RECEPTOR; FC RECEPTOR LIKE 1 MOLECULE; FC RECEPTOR LIKE 3 MOLECULE; FC RECEPTOR LIKE 4 MOLECULE; FC RECEPTOR LIKE 5 MOLECULE; FC RECEPTOR LIKE 6 MOLECULE; FC RECEPTOR LIKE MOLECULE; GLYCOPROTEIN P 15095; PROGRAMMED DEATH 1 RECEPTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN FC FRAGMENT;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHROMOSOME 1; CHROMOSOME 3; CHROMOSOME TRANSLOCATION; FCRL GENE; GENE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GERMINAL CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHATIC LEUKEMIA; LYMPHOMA; MEMORY CELL; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; VIREMIA; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MOUSE; NEOPLASM; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; NEOPLASMS; RECEPTORS, FC;

EID: 78650662876     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-88     Document Type: Article

References (50)

1. Chikaev NA, Bykova EA, Najakshin AM, Mechetina LV, Volkova OY, Peklo MM, Shevelev AY, Vlasik TN, Roesch A, Vogt T, Taranin AV (2005) Cloning and characterization of the human FCRL2 gene. Genomics 85:264-272 (Pubitemid 40164792)
2. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840-1847 (Pubitemid 29430399)
3. Davis RS (2007) Fc receptor-like molecules. Annu Rev Immunol 25:525-560 (Pubitemid 46697916)
4. Davis RS, Wang YH, Kubagawa H, Cooper MD (2001) Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 98:9772-9777 (Pubitemid 32769379)
5. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354 (Pubitemid 44435155)
6. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD (2003) The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci USA 100:13489-13494 (Pubitemid 37444769)
7. Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, Davis RS, Cooper MD (2005) Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 202:783-791 (Pubitemid 41345967)
8. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD (2008) Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med 205:1807-1817
9. Falini B, Tiacci E, Pucciarini A, Bigerna B, Kurth J, Hatzivassiliou G, Droetto S, Galletti BV, Gambacorta M, Orazi A, Pasqualucci L, Miller I, Kuppers R, Dalla-Favera R, Cattoretti G (2003) Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 102:3684-3692 (Pubitemid 37409389)
10. Goodman GR, Bethel KJ, Saven A (2003) Hairy cell leukemia: An update. Curr Opin Hematol 10:258-266 (Pubitemid 36724348)
11. Guselnikov SV, Ershova SA,Mechetina LV, NajakshinAM, VolkovaOY, Alabyev BY, Taranin AV (2002) A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1. Immunogenetics 54:87-95 (Pubitemid 34809704)
12. Haga CL, Ehrhardt GR, Boohaker RJ, Davis RS, Cooper MD (2007) Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc Natl Acad Sci USA 104:9770-9775 (Pubitemid 47175342)
13. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848-1854 (Pubitemid 29430400)
14. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, Tagawa S, Taniwaki M, Russo J, Neri A, Cattoretti G, Clynes R, Mendelsohn C, Chaganti RS, Dalla-Favera R (2001) IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14:277-289 (Pubitemid 32289292)
15. Hu X, ChangM, Saiki RK, CargillMA, BegovichAB, Ardlie KG, Criswell LA, SeldinMF, Amos CI, Gregersen PK, Kastner DL, Remmers EF (2006) The functional -169T->C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 54:1022-1025
16. Huttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, Nuckel H, Ebeling P, Fuhrer A, Edelmann J, Sellmann L, Duhrsen U, Durig J (2006) Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 20:1774-1782 (Pubitemid 44574989)
17. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, Kamatani N (2006) Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 65:671-673
18. Ise T, Maeda H, Santora K, Xiang L, Kreitman RJ, Pastan I, Nagata S (2005) Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies. Clin Cancer Res 11:87-96 (Pubitemid 40075782)
19. Ise T, Nagata S, Kreitman RJ, Wilson WH, Wayne AS, Stetler-Stevenson M, Bishop MR, Scheinberg DA, Rassenti L, Kipps TJ, Kyle RA, Jelinek DF, Pastan I (2007) Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia 21:169-174 (Pubitemid 44921849)
20. Johrens K, Shimizu Y, Anagnostopoulos I, Schiffmann S, Tiacci E, Falini B, Stein H (2005) T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. Haematologica 90:1070-1077 (Pubitemid 41323506)
21. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae SC, Tokuhiro S, Chang X, Sekine A, Takahashi A, Tsunoda T, Ohnishi Y, Kaufman KM, Kang CP, Kang C, Otsubo S, Yumura W, Mimori A, Koike T, Nakamura Y, Sasazuki T, Yamamoto K (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37:478-485 (Pubitemid 40617275)
22. Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, Nakamura Y, Yamamoto K (2009) FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptormediated signaling. J Immunol 183:5502-5510
23. Lazzi S, Bellan C, Tiacci E, Palummo N, Vatti R, Oggioni M, Amato T, Schuerfeld K, Tonini T, Tosi P, Falini B, Leoncini L (2006) IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. J Pathol 209:56-66
24. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Fc receptor-like 3-169 C/T polymorphism and RA susceptibility: A meta-analysis. Rheumatol Int 30:947-953
25. Leu CM, Davis RS, Gartland LA, Fine WD, Cooper MD (2005) FcRH1: An activation coreceptor on human B cells. Blood 105:1121-1126 (Pubitemid 40170884)
26. Li FJ, Ding S, Pan J, ShakhmatovMA, Kashentseva E, Wu J, Li Y, Soong SJ, Chiorazzi N, Davis RS (2008) FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112:179-187
27. Maltais LJ, Lovering RC, Taranin AV, Colonna M, Ravetch JV, Dalla-Favera R, Burrows PD, Cooper MD, Davis RS (2006) New nomenclature for Fc receptor-like molecules. Nat Immunol 7:431-432
28. Mechetina LV, Najakshin AM, Volkova OY, Guselnikov SV, Faizulin RZ, Alabyev BY, Chikaev NA, Vinogradova MS, Taranin AV (2002) FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur J Immunol 32:87-96 (Pubitemid 34092825)
29. Mestas J, Hughes CC (2004) Of mice and not men: Differences between mouse and human immunology. J Immunol 172:2731-2738 (Pubitemid 38263654)
30. Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R (2002) IRTAs: A new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 99:2662-2669 (Pubitemid 34525350)
31. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, Roby G, Kottilil S, Arthos J, Proschan MA, Chun TW, Fauci AS (2008) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205:1797-1805
32. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV (1994) A 13-aminoacid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 368:70-73 (Pubitemid 24073879)
33. Nagata S, Ise T, Pastan I (2009) Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 182:7518-7526
34. Nakayama Y, Weissman SM, Bothwell AL (2001) BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells. Biochem Biophys Res Commun 285:830-837 (Pubitemid 32924845)
35. Nuckel H, Collins CH, Frey UH, Sellmann L, Durig J, Siffert W, Duhrsen U (2009) FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia. Eur J Haematol 83:541-549
36. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 98:13866-13871 (Pubitemid 33115990)
37. Polson AG, Zheng B, Elkins K, Chang W, Du C, Dowd P, Yen L, Tan C, Hongo JA, Koeppen H, Ebens A (2006) Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int Immunol 18:1363-1373 (Pubitemid 44446830)
38. Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, van der Burg M, van Dongen JJ, Wiech E, Visentini M, Quinti I, Prasse A, Voelxen N, Salzer U, Goldacker S, Fisch P, Eibel H, Schwarz K, Peter HH, Warnatz K (2009) Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci USA 106:13451-13456
39. Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290:84-89
40. Reth M (1992) Antigen receptors on B lymphocytes. Annu Rev Immunol 10:97-121
41. Sanchez E, Callejas JL, Sabio JM, de Haro M, Camps M, de Ramon E, Garcia-Hernandez FJ, Koeleman B, Martin J, Gonzalez-Escribano MF (2006) Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 45:1044-1046 (Pubitemid 44283066)
42. Schreeder DM, Pan J, Li FJ, Vivier E, Davis RS (2008) FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur J Immunol 38:3159-3166
43. Shlapatska LM, Mikhalap SV, Berdova AG, Zelensky OM, Yun TJ, Nichols KE, Clark EA, Sidorenko SP (2001) CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol 166:5480-5487 (Pubitemid 32374169)
44. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC (2006) Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab 91:1056-1061 (Pubitemid 43357780)
45. Swainson LA, Mold JE, Bajpai UD, McCune JM (2010) Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 184:3639-3647
46. Takata Y, Inoue H, Sato A, Tsugawa K, Miyatake K, Hamada D, Shinomiya F, Nakano S, Yasui N, Tanahashi T, Itakura M(2008) Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: Results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 53:163-173
47. Vely F, Vivier E (1997) Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J Immunol 159:2075-2077 (Pubitemid 127680992)
48. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B, Kayentao K, Ongoiba A, Doumbo OK, Pierce SK (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183:2176-2182
49. Wilson TJ, Presti RM, Tassi I, Overton ET, Cella M, Colonna M (2007) FcRL6, a new ITIMbearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection. Blood 109:3786-3793 (Pubitemid 46641729)
50. Xu MJ, Zhao R, Zhao ZJ (2001) Molecular cloning and characterization of SPAP1, an inhibitory receptor. Biochem Biophys Res Commun 280:768-775 (Pubitemid 32924496)